Silymarin for the Prevention of Atrial Fibrillation After Cardiac Surgery
Status:
Recruiting
Trial end date:
2025-07-01
Target enrollment:
Participant gender:
Summary
The study is a prospective, randomized, controlled trial to assess the effects of silymarin
on the occurrence of postoperative atrial fibrillation after coronary artery bypass graft
surgery.